(RTTNews) - Nasdaq (NDAQ) announced that AstraZeneca PLC - ADR (AZN), will become a component of the NASDAQ-100 Index (NDX) and the NASDAQ-100 Equal Weighted Index (NDXE) prior to market open on February 22, 2022. AstraZeneca PLC - ADR will replace Xilinx Inc. (XLNX) in the NASDAQ-100 Index® and the NASDAQ-100 Equal Weighted Index.
Advanced Micro Devices (AMD) is acquiring Xilinx in a transaction expected to be completed on or about February 14.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.